Bremer Bank National Association’s Perspective Therapeutics CATX Stock Holding History

Bremer Bank National Association’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,941	Closed	-$7K	–	195
2022 Q4	$7K	Hold	2,941	–	–	﹤0.01%	203
2022 Q3	$7K	Hold	2,941	–	–	﹤0.01%	190
2022 Q2	$9K	Hold	2,941	–	–	﹤0.01%	216
2022 Q1	$11K	Hold	2,941	–	–	﹤0.01%	224
2021 Q4	$11K	Hold	2,941	–	–	﹤0.01%	220
2021 Q3	$19K	Hold	2,941	–	–	﹤0.01%	201
2021 Q2	$23K	Hold	2,941	–	–	﹤0.01%	209
2021 Q1	$32K	Buy	+2,941	New	+$44.4K	0.01%	203

Other funds holding CATX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCM

Osterweis Capital Management San Francisco, California $1.94B AUM 20.77% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

TMWM

Taylor & Morgan Wealth Management Flint, Michigan $203M AUM 24.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bremer Bank National Association's CATX Position: Q1 2023 in Review

Bremer Bank National Association sold out of Perspective Therapeutics (CATX) in Q1 2023, closing a stake of 2,941 shares — an estimated $7K sold.

Bremer Bank National Association first reported a position in CATX in Q1 2021 and held it in 8 quarters. The position peaked at $32K in Q1 2021. 42 funds tracked by Wall St. Rank hold CATX as of Q1 2023.

Bremer Bank National Association reported no remaining Perspective Therapeutics position as of Q1 2023 after selling out during the quarter.
Bremer Bank National Association sold 2,941 Perspective Therapeutics shares in Q1 2023, an estimated $7K.
Bremer Bank National Association first reported a position in Perspective Therapeutics in Q1 2021 and held it in 8 quarters.
Bremer Bank National Association's Perspective Therapeutics position peaked at $32K in Q1 2021.
42 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2023.

Based on Bremer Bank National Association's 13F filing for Q1 2023, filed 13 Apr 2023.